Mechanism of Action of Potassium-Sparing Diuretics

Introduction

Potassium-sparing diuretics are a group of diuretic drugs that increase sodium and water excretion while conserving potassium. They are mainly used in hypertension, heart failure, hyperaldosteronism, and conditions associated with potassium loss caused by other diuretics. Unlike loop and thiazide diuretics, potassium-sparing diuretics reduce potassium excretion and help prevent hypokalemia.


Mechanism of Action (Step-wise)

  1. Potassium-sparing diuretics act in the late distal convoluted tubule and collecting duct of the nephron.
  2. They are classified into two groups: aldosterone antagonists and epithelial sodium channel (ENaC) blockers.
  3. Aldosterone antagonists such as spironolactone and eplerenone competitively block mineralocorticoid (aldosterone) receptors.
  4. Aldosterone normally increases synthesis of ENaC channels and Na⁺/K⁺-ATPase pumps.
  5. Blocking aldosterone reduces sodium reabsorption and potassium secretion.
  6. ENaC blockers such as amiloride and triamterene directly inhibit epithelial sodium channels in principal cells.
  7. Reduced sodium entry into principal cells decreases activity of the Na⁺/K⁺-ATPase.
  8. This lowers potassium secretion into the tubular lumen.
  9. Sodium and water excretion increase mildly.
  10. Potassium retention occurs because less potassium is exchanged for sodium.
  11. The overall effect is mild diuresis with conservation of potassium.

A key exam point is that potassium-sparing diuretics reduce potassium excretion while promoting mild sodium and water loss.

Mechanism of Action of Potassium-Sparing Diuretics Flowchart
Flowchart of mechanism of action of Potassium-Sparing Diuretics
MOA of Potassium-Sparing Diuretics
Mechanism of action of Potassium-Sparing Diuretics

Pharmacokinetics

Potassium-sparing diuretics are administered orally. Spironolactone is metabolized extensively in the liver to active metabolites. Eplerenone has a shorter duration and greater receptor selectivity. Amiloride and triamterene are excreted mainly by the kidneys. The onset of action of aldosterone antagonists is slower because they alter protein synthesis.


Clinical Uses

Potassium-sparing diuretics are used in hypertension and heart failure, often in combination with loop or thiazide diuretics to prevent hypokalemia. Spironolactone is especially useful in primary hyperaldosteronism, resistant hypertension, and heart failure with reduced ejection fraction. They are also used in ascites associated with liver cirrhosis.


Adverse Effects

The major adverse effect is hyperkalemia, especially in patients with renal impairment or those receiving ACE inhibitors. Spironolactone may cause gynecomastia, impotence, and menstrual irregularities due to antiandrogen effects. Other effects include nausea and dizziness.


Comparative Analysis

FeaturePotassium-Sparing DiureticsLoop DiureticsThiazide Diuretics
Site of actionCollecting ductThick ascending limbDistal convoluted tubule
Potassium effectRetain potassiumIncrease potassium lossIncrease potassium loss
Diuretic strengthMildStrongModerate
Main mechanismAldosterone blockade or ENaC inhibitionNa⁺-K⁺-2Cl⁻ inhibitionNa⁺-Cl⁻ inhibition
Hyperkalemia riskHighLowLow
Typical usePrevent hypokalemiaEdema, HFHypertension

Potassium-sparing diuretics differ from loop and thiazide diuretics because they conserve potassium instead of causing potassium wasting. Aldosterone antagonists additionally provide cardiovascular benefits in heart failure.


MCQs

  1. Potassium-sparing diuretics act mainly in the:
    a) Proximal tubule
    b) Loop of Henle
    c) Collecting duct
    d) Glomerulus

Answer: c) Collecting duct

  1. Spironolactone blocks which receptor?
    a) β1 receptor
    b) Mineralocorticoid receptor
    c) H1 receptor
    d) Dopamine receptor

Answer: b) Mineralocorticoid receptor

  1. Amiloride directly blocks:
    a) Na⁺-K⁺-2Cl⁻ transporter
    b) ENaC channels
    c) Calcium channels
    d) H⁺ pumps

Answer: b) ENaC channels

  1. Potassium-sparing diuretics cause:
    a) Potassium loss
    b) Potassium retention
    c) Calcium loss only
    d) Sodium retention

Answer: b) Potassium retention

  1. The major adverse effect is:
    a) Hypokalemia
    b) Hyperkalemia
    c) Hypercalcemia
    d) Hypoglycemia

Answer: b) Hyperkalemia

  1. Spironolactone is useful in:
    a) Hyperaldosteronism
    b) Diabetes insipidus
    c) Asthma
    d) Epilepsy

Answer: a) Hyperaldosteronism

  1. Aldosterone normally increases:
    a) ENaC expression
    b) Histamine release
    c) Dopamine secretion
    d) Insulin production

Answer: a) ENaC expression

  1. Potassium-sparing diuretics produce which degree of diuresis?
    a) Very strong
    b) Mild
    c) None
    d) Extreme

Answer: b) Mild

  1. Spironolactone may cause:
    a) Gynecomastia
    b) Ototoxicity
    c) Hyperglycemia
    d) Bradycardia

Answer: a) Gynecomastia

  1. ENaC blockers reduce:
    a) Sodium entry into principal cells
    b) Calcium entry into muscle
    c) Histamine release
    d) Glucose absorption

Answer: a) Sodium entry into principal cells

  1. Potassium-sparing diuretics are often combined with:
    a) Antifungals
    b) Loop diuretics
    c) Antivirals
    d) Antacids

Answer: b) Loop diuretics

  1. Compared to loop diuretics, potassium-sparing diuretics:
    a) Cause more potassium loss
    b) Preserve potassium
    c) Have stronger diuresis
    d) Cause severe ototoxicity

Answer: b) Preserve potassium


FAQs

What is the mechanism of action of potassium-sparing diuretics?
They reduce sodium reabsorption and potassium secretion in the collecting duct.

Why are they called potassium-sparing?
Because they decrease urinary potassium loss.

What is the difference between spironolactone and amiloride?
Spironolactone blocks aldosterone receptors, while amiloride blocks ENaC channels directly.

What is the major adverse effect?
Hyperkalemia.

Why is spironolactone useful in heart failure?
It blocks harmful effects of aldosterone and improves survival.

Can spironolactone cause hormonal side effects?
Yes, gynecomastia and menstrual irregularities may occur.


References

Goodman & Gilman’s The Pharmacological Basis of Therapeutics – Diuretics
https://accessmedicine.mhmedical.com/book.aspx?bookid=3191

Katzung: Basic and Clinical Pharmacology – Diuretic Agents
https://accessmedicine.mhmedical.com/content.aspx?bookid=3382

Tripathi: Essentials of Medical Pharmacology – Diuretics
https://www.jaypeedigital.com

Harrison’s Principles of Internal Medicine – Heart Failure and Hypertension
https://accessmedicine.mhmedical.com

Author

  • Harsh Singh Author Pharmacy Freak

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators